Table 4.
Comparison of the values before and after 6 months
| Variable | Previous | After 6 months | P |
|---|---|---|---|
| n | 132 | 132 | |
| CFS | 3.92 ± 2.18 | 4.19 ± 2.18 | <0.001 |
| HbA1c (%) | 7.13 ± 0.99 | 6.89 ± 0.91 | <0.01 |
| Bodyweight (kg) | 57.01 ± 11.99 | 55.88 ± 11.85 | <0.01 |
| HDL‐C (mmol/L) | 1.36 ± 0.42 | 1.30 ± 0.43 | NS |
| T‐chol (mmol/L) | 4.63 ± 1.09 | 4.49 ± 1.12 | NS |
| Alb (g/L) | 39.18 ± 5.01 | 38.68 ± 5.34 | NS |
| SBP (kPa) | 17.26 ± 2.04 | 17.07 ± 2.08 | NS |
| Diabetes medications | |||
| Insulin, sulfonylurea, glinide | 63 (47.73) | 59 (44.70) | NS |
| Others | 69 (52.27) | 73 (55.30) | NS |
Data are expressed as means ± SD. Data of diabetes medications are shown n (%). The comparisons were carried out by Wilcoxon signed rank test for the median of CFS, and the paired Student's t‐test for the others. Values were statistically significant at P < 0.05. Alb, albumin; CFS, Clinical Frailty Scale; HbA1c, glycated hemoglobin; HDL‐C, high‐density lipoprotein cholesterol; NS, not significant; SBP, systolic blood pressure; T‐chol, total cholesterol.